• Services
    • Overview
    • Antibody Profiling Solutions
    • Oncology Drug Screening
    • Immunoprofiling
    • Vaccine Development
    • Custom Protein Arrays
  • Applications
        • Disease Area
          • Autoimmune Disease
          • Immuno-Oncology
          • Neurological Disease
          • Infectious Disease
        • Application Area
          • Biomarker Discovery
          • Patient Stratification
          • Disease and Treatment Outcome Prediction
          • Diagnostics & CDx Development
  • Technology
    • Overview
    • KREX Protein Folding Technology
    • Antibodies as Biomarkers
    • Bioinformatics for Antibody Profiling
  • Resources
    • Blog
    • Videos
    • Featured Publications
    • Product Information
    • White Paper & Case Studies
    • Protein List
    • FAQs
  • About
    • Company Overview
      • Patents
    • Meet Our Team
    • News & Events
  • Menu Menu
  • Join Our Team
  • Contact

White Papers & Case Studies

See how Sengenics accelerates biomarker discovery

  • Autoimmune
  • Technology
  • Cancer
  • Neurodegeneration
  • Drug Discovery and Toxicology

Autoimmune

Anti-Cytokine Autoantibodies in Health, Disease, and Treatment

View Paper

Citrullination in Disease: Emerging Insights and Implications

View Paper

The potential of immunoproteomics in type 2 diabetes as a diagnostic and prognostic tool to combat bacterial infection

View Paper

Technology

i-Ome Discovery – The Power of Precision

View Paper

Immunoprofiling – The Role of Antibody Isotypes

View Paper

Bioinformatics for Immunoprofiling with Protein Microarrays

View Paper

Antibody-Antigen Binding: Shape Matters

View Paper

Isotypes Diving Deeper into Immunoprofiling

View Paper

Historical Timeline – Milestones in Humoral Immunity

View Paper

Antibody Profiling: Decoding the Humoral Immune System

View Paper

Exploring Diverse Protein Interactions using the Sengenics Protein Array

View Paper

Cancer

Next-Generation Biomarkers in Cancer Precision Medicine

View Paper

eBook: Immunoprofiling & the Humoral Immune System

View Paper

A Conversation with Dr. Iman Osman – Developing a Program to Predict irAEs and Therapeutic Outcomes in Immunotherapy

View Paper

Neurodegeneration

A Liquid Biopsy for Neurodegenerative Diseases

View Paper

eBook: Immunoprofiling & the Humoral Immune System

View Paper

Poster: Identification of novel autoantibody signatures related to non-motor symptoms in individuals with high-risk of Parkinson’s Disease, using KREX-based functional protein microarrays. A cross-sectional study.

View Paper

Drug Discovery and Toxicology

Address Key Challenges in Vaccine Development with Antibody Profiling

View Paper

KREX Protein Arrays for Rapid Screening of Vaccine Candidates

View Paper

Ready to accelerate your program?

Let’s discuss your needs

  • Services
  • Applications
  • Technology
  • Resources
  • About

Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.

© 2024 Sengenics Corporation LLC. All rights reserved. Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D

Terms & Conditions | Terms of Use | Privacy Statement | Cookie Policy | Code of Conduct | Whistleblowing Policy | Sitemap

Design and development by RainCastle Communications.

"*" indicates required fields

Fill in the form to download the publication

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

"*" Indicates required fields

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation


Read the Review

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.

"*" indicates required fields

Watch the video

By proceeding, I agree to Sengenics’ Terms of Use and acknowledge that I have read the Privacy Policy.
I also agree that Sengenics or its representatives may contact me by email at the email address I provide, including for marketing purposes.

This field is for validation purposes and should be left unchanged.